Sorafenib as third- or fourth-line treat
✍
Montemurro, M.; Gelderblom, H.; Bitz, U.; Schütte, J.; Blay, J.Y.; Joensuu, H.;
📂
Article
📅
2013
🏛
Elsevier Science
🌐
English
⚖ 254 KB